Delivery Order SPE2DB24D6039-SPE2DB25FLELT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,578.64 to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML, a ciprofloxacin-based antibiotic pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating...
- The Defense Logistics Agency awarded a delivery order valued at $4,210.72 to AmerisourceBergen Drug Corp for Cipro 10% Suspension 100ML, a broad-spectrum antibiotic pharmaceutical product. The contract utilized firm fixed price pricing with no set-aside designation, indicating competitive award through an open procurement process. The delivery order is scheduled for completion by August 1, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,638.66 delivery order to AmerisourceBergen Drug Corp for Cipro 5% suspension (100mL) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is located...
- The Defense Logistics Agency awarded a delivery order valued at $1,461.98 to AmerisourceBergen Drug Corp for Cipro 5% Suspension in 100ml quantities, with a firm fixed price contract type. The award was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $1,089.72 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procedures with no set-aside designation, and the product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cipro 5% suspension in 100ml quantities, with a ceiling value of $1,332.60 under a firm fixed-price contract structure. This non-competitive delivery order was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery supports the federal...
- The Defense Logistics Agency awarded a $2,967.88 delivery order to AmerisourceBergen Drug Corp for 100ml of Cipro 5% Suspension on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed price contract represents a non-set-aside award issued under competitive procurement procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,143.32 to AmerisourceBergen Drug Corp for Cipro 5% Suspension in 100ml quantities on September 3, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a $1,875.75 delivery order to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML on September 12, 2025, with completion scheduled by September 15, 2025. This firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made competitively without set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cipro 5% Suspension in 100ml quantities, with a ceiling value of $2,103.45. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025. The award was made on a competitive, non-set-aside basis and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D6039Indefinite Delivery Contract
- SPE2DB24D6039-SPE2DB25FLELTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,240.05 to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML, a fluoroquinolone antibiotic commonly used to treat bacterial infections across military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of the pharmaceutical supply chain managed through the Defense Logistics Agency's Medical Supply Chain division. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp fulfills medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism, with the DLA planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts for separate regional coverage.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/12/25 |